NVO: 诺和诺德公司
今日NVO汇率已更改-1.87%。当日,交易品种以低点46.04和高点46.74进行交易。
关注诺和诺德公司动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVO新闻
- Opinion: Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
- AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
- Oura files for IPO amid Americans’ obsession with tracking their sleep, steps and heart rates
- Pfizer's Pipeline Strategy Centers on Obesity and Oncology
- HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss
- Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications - Hims & Hers Health (NYSE:H
- GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit?
- Trump Expands Drug Pricing Agreements With 9 Drugmakers— RFK Jr. Says President Called ‘Every Hour’ to En
- Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
- LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
- Can CagriSema Help Novo Nordisk Close the Gap With LLY in Obesity?
- Novo Nordisk: Why The Price Remains Stubbornly Low (Rating Downgrade) (NYSE:NVO)
- Hims & Hers: The Amazon Of Personalized Healthcare Is Emerging (NYSE:HIMS)
- Biohaven: Buy Reiterated On Opakalim License Agreement For Epilepsy And More (NYSE:BHVN)
- Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak
- Boston Scientific Reports Global Disruption After Cybersecurity Incident - Boston Scientific (NYSE:BSX)
- NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?
- LLY vs. ABBV: Which Stock Has the Stronger Growth Prospects?
- Amgen Touches 52-Week High: Buy, Sell or Hold the Stock?
- Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)
- Novo Nordisk: The Pill That Could Close The Gap With Lilly (NYSE:NVO)
- Making Drugs With AI: Biopharma Giants Gear Up For New Arena
- Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear Winner
- Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s?
常见问题解答
NVO股票今天的价格是多少?
诺和诺德公司股票今天的定价为46.63。它在46.04 - 46.74范围内交易,昨天的收盘价为47.52,交易量达到10115。NVO的实时价格图表显示了这些更新。
诺和诺德公司股票是否支付股息?
诺和诺德公司目前的价值为46.63。股息政策取决于公司,而投资者也会关注-16.75%和USD。实时查看图表以跟踪NVO走势。
如何购买NVO股票?
您可以以46.63的当前价格购买诺和诺德公司股票。订单通常设置在46.63或46.93附近,而10115和0.67%显示市场活动。立即关注NVO的实时图表更新。
如何投资NVO股票?
投资诺和诺德公司需要考虑年度范围35.13 - 64.16和当前价格46.63。许多人在以46.63或46.93下订单之前,会比较1.77%和。实时查看NVO价格图表,了解每日变化。
诺和诺德公司股票的最高价格是多少?
在过去一年中,诺和诺德公司的最高价格是64.16。在35.13 - 64.16内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪诺和诺德公司的绩效。
诺和诺德公司股票的最低价格是多少?
诺和诺德公司(NVO)的最低价格为35.13。将其与当前的46.63和35.13 - 64.16进行比较,可以发现潜在的长期切入点。观看NVO在图表上的实时走势以获取更多详细信息。
NVO股票是什么时候拆分的?
诺和诺德公司历史上曾经历过股票拆分。这些变化在公司行动后的、47.52和-16.75%中可见。
- 前一天收盘价
- 47.52
- 开盘价
- 46.32
- 卖价
- 46.63
- 买价
- 46.93
- 最低价
- 46.04
- 最高价
- 46.74
- 交易量
- 10.115 K
- 日变化
- -1.87%
- 月变化
- 1.77%
- 6个月变化
- 26.82%
- 年变化
- -16.75%